Contact
searchSearch
HMP Global

Parkinson Disease Topic Center

Featured Article

News
Depression Increases Risk of Parkinson Disease, Dementia, and Mortality, Study Finds
10/10/2024
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease...
10/10/2024
Annals of Long-Term Care
News
Parkinson's Foundation Invests $3 Million in Groundbreaking Research to Accelerate Treatment Breakthroughs
09/10/2024
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has...
09/10/2024
Annals of Long-Term Care
News
At-Home Intracranial Recordings Reveal Circadian Rhythms in Patients with PD
08/27/2024
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi)...
08/27/2024
Annals of Long-Term Care
News
PD-Related Genes Contribute to Disease in 15% of Patients
08/05/2024
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
MRI-Guided Focused Ultrasound Subthalamotomy for Treating Parkinson Disease
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care
News
Researchers Use AI to Predict Parkinson Disease Up to 7 Years
06/20/2024
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood...
06/20/2024
Annals of Long-Term Care
News
Investigational PD Cell Therapy Receives FDA RMAT Designation
06/06/2024
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug...
06/06/2024
Annals of Long-Term Care
News
Exposure to Airborne Manganese, Beryllium, and Nickel May Increase the Risk of Parkinson Disease
05/21/2024
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to...
05/21/2024
Annals of Long-Term Care
News
Neurostimulation Produces a Stable Quality of Life Up to 5 Years in Patients With Parkinson Disease, Study Finds
05/08/2024
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the...
05/08/2024
Annals of Long-Term Care
News
Improving Patient Engagement in Value-Based Care
04/09/2024

Emry Lloyd

Emry Lloyd
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients...
04/09/2024
Annals of Long-Term Care
News
Skin Biopsies Show Promise as Diagnostic Tool for Synucleinopathies Such as Parkinson Disease
04/04/2024
Skin biopsies may hold promise as a diagnostic tool for synucleinopathies like Parkinson disease, with high rates of phosphorylated α-synuclein detected in affected individuals compared to controls.
Skin biopsies may hold promise as a diagnostic tool for synucleinopathies like Parkinson disease, with high rates of phosphorylated α-synuclein detected in affected individuals compared to controls.
Skin biopsies may hold promise...
04/04/2024
Annals of Long-Term Care

Newsfeed

News
Depression Increases Risk of Parkinson Disease, Dementia, and Mortality, Study Finds
10/10/2024
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease...
10/10/2024
Annals of Long-Term Care
News
Parkinson's Foundation Invests $3 Million in Groundbreaking Research to Accelerate Treatment Breakthroughs
09/10/2024
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has...
09/10/2024
Annals of Long-Term Care
News
At-Home Intracranial Recordings Reveal Circadian Rhythms in Patients with PD
08/27/2024
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi)...
08/27/2024
Annals of Long-Term Care
News
PD-Related Genes Contribute to Disease in 15% of Patients
08/05/2024
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
MRI-Guided Focused Ultrasound Subthalamotomy for Treating Parkinson Disease
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care
News
Researchers Use AI to Predict Parkinson Disease Up to 7 Years
06/20/2024
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood...
06/20/2024
Annals of Long-Term Care
News
Investigational PD Cell Therapy Receives FDA RMAT Designation
06/06/2024
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug...
06/06/2024
Annals of Long-Term Care
News
Exposure to Airborne Manganese, Beryllium, and Nickel May Increase the Risk of Parkinson Disease
05/21/2024
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to...
05/21/2024
Annals of Long-Term Care
News
Neurostimulation Produces a Stable Quality of Life Up to 5 Years in Patients With Parkinson Disease, Study Finds
05/08/2024
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the...
05/08/2024
Annals of Long-Term Care
News
Improving Patient Engagement in Value-Based Care
04/09/2024

Emry Lloyd

Emry Lloyd
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients...
04/09/2024
Annals of Long-Term Care
News
Women Face Higher Mortality Risk from Postoperative Atrial Fibriliation Despite Lower Incidence Postsurgery
11/14/2024
While men are more likely to develop postoperative atrial fibrillation (poAF) after open-heart surgery, women with poAF face a higher risk of long-term mortality compared to men.
While men are more likely to develop postoperative atrial fibrillation (poAF) after open-heart surgery, women with poAF face a higher risk of long-term mortality compared to men.
While men are more likely to...
11/14/2024
Annals of Long-Term Care
News
Study Reveals Key Predictors of Dementia Risk in Patients With Parkinson Disease
11/01/2024
Age, sex, and education are key dementia risks in Parkinson disease.
Age, sex, and education are key dementia risks in Parkinson disease.
Age, sex, and education are key...
11/01/2024
Annals of Long-Term Care
News
Adaptive Deep Brain Stimulation Shows Promise in Enhancing Parkinson Disease Treatment
10/25/2024
Personalized adaptive deep brain stimulation may offer better control of motor symptoms and enhance quality of life compared to standard treatment approaches in Parkinson disease.
Personalized adaptive deep brain stimulation may offer better control of motor symptoms and enhance quality of life compared to standard treatment approaches in Parkinson disease.
Personalized adaptive deep brain...
10/25/2024
Annals of Long-Term Care
News
Investigating a Potential Link Between Inflammation and Cardiac Arrhythmia
10/23/2024
Researchers investigated how immune cells in human epicardial adipose tissue (EAT) contribute to atrial fibrillation (AF), revealing a potential link between inflammation and cardiac arrhythmia according to research published in Nature...
Researchers investigated how immune cells in human epicardial adipose tissue (EAT) contribute to atrial fibrillation (AF), revealing a potential link between inflammation and cardiac arrhythmia according to research published in Nature...
Researchers investigated how...
10/23/2024
Annals of Long-Term Care
News
Depression Increases Risk of Parkinson Disease, Dementia, and Mortality, Study Finds
10/10/2024
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease...
10/10/2024
Annals of Long-Term Care
News
Parkinson's Foundation Invests $3 Million in Groundbreaking Research to Accelerate Treatment Breakthroughs
09/10/2024
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has...
09/10/2024
Annals of Long-Term Care
News
At-Home Intracranial Recordings Reveal Circadian Rhythms in Patients with PD
08/27/2024
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi)...
08/27/2024
Annals of Long-Term Care
News
Bibliometric Analysis Reveals Growing Research Focus and Global Impact of Parkinson Disease Economic Burden
08/19/2024
Research on the economic burden of Parkinson disease (PD) has grown significantly in recent years, highlighting the increasing global impact of this neurodegenerative disorder, according to a study published in the Journal of Public Health.
Research on the economic burden of Parkinson disease (PD) has grown significantly in recent years, highlighting the increasing global impact of this neurodegenerative disorder, according to a study published in the Journal of Public Health.
Research on the economic burden...
08/19/2024
Annals of Long-Term Care
News
PD-Related Genes Contribute to Disease in 15% of Patients
08/05/2024
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
MRI-Guided Focused Ultrasound Subthalamotomy for Treating Parkinson Disease
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care

Insights

Headshot of Dr Ruth Schneider on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Treatment Efficacy for Parkinson Disease-Related Anxiety
06/29/2021
Ruth Schneider, MD, assistant professor and director, Huntington’s Disease Society of America Center of Excellence, University of Rochester, discusses her recent research that examined patient outcomes and responses to buspirone in the...
Ruth Schneider, MD, assistant professor and director, Huntington’s Disease Society of America Center of Excellence, University of Rochester, discusses her recent research that examined patient outcomes and responses to buspirone in the...
Ruth Schneider, MD, assistant...
06/29/2021
Annals of Long-Term Care
Beneficial Treatments for OFF Episodes Among Patients With PD
Videos
Beneficial Treatments for OFF Episodes Among Patients With PD
02/18/2021
Maria C Ospina, MD, movement disorder neurologist, discusses how physicians can ensure they receive all of the information needed to unlock patterns of Parkinson disease among their patients, and breaks down treatment options for OFF episodes...
Maria C Ospina, MD, movement disorder neurologist, discusses how physicians can ensure they receive all of the information needed to unlock patterns of Parkinson disease among their patients, and breaks down treatment options for OFF episodes...
Maria C Ospina, MD, movement...
02/18/2021
Annals of Long-Term Care
Parkinson Disease: Therapeutic Interventions and How Care Has Changed Since COVID First Struck
Videos
Parkinson Disease: Therapeutic Interventions and How Care Has Changed Since COVID First Struck
11/17/2020
Luca Marsili MD, PhD, Gardner Family Center for Parkinson's Disease and Movement Disorders, discusses how the care of Parkinson disease (PD) has changed since the start of the pandemic and explains why guidelines for choosing the appropriate...
Luca Marsili MD, PhD, Gardner Family Center for Parkinson's Disease and Movement Disorders, discusses how the care of Parkinson disease (PD) has changed since the start of the pandemic and explains why guidelines for choosing the appropriate...
Luca Marsili MD, PhD, Gardner...
11/17/2020
Annals of Long-Term Care
Interview
A Potential Blood Test for Parkinson Disease
05/14/2019
Despite Parkinson disease diagnosis challenges, new research shines light on a potential noninvasive diagnostic test. Professor of neurology at the Brain Research Institute Gal Bitan, PhD, discusses his recent study findings.
Despite Parkinson disease diagnosis challenges, new research shines light on a potential noninvasive diagnostic test. Professor of neurology at the Brain Research Institute Gal Bitan, PhD, discusses his recent study findings.
Despite Parkinson disease...
05/14/2019
Annals of Long-Term Care
Interview
Determining Appropriate Time to Initiate PD Treatment
03/12/2019
Rob di Bie, MD, PhD, neurologist and professor of Movement Disorders at the University of Amsterdam’s Faculty of Medicine, discusses the long-term effects of a specific PD medication and the impact of starting the drug early.
Rob di Bie, MD, PhD, neurologist and professor of Movement Disorders at the University of Amsterdam’s Faculty of Medicine, discusses the long-term effects of a specific PD medication and the impact of starting the drug early.
Rob di Bie, MD, PhD, neurologist...
03/12/2019
Annals of Long-Term Care
Podcasts
Is it Safe to Treat PD With a Drug Approved for Psuedobulbar Affect?
02/21/2019
Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why...
Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why...
Michael Fralick, MD, FRCPC,...
02/21/2019
Annals of Long-Term Care
Annals of Long-Term Care Newsletter

Recent Content

News
Depression Increases Risk of Parkinson Disease, Dementia, and Mortality, Study Finds
10/10/2024
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease...
10/10/2024
Annals of Long-Term Care
News
Parkinson's Foundation Invests $3 Million in Groundbreaking Research to Accelerate Treatment Breakthroughs
09/10/2024
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has...
09/10/2024
Annals of Long-Term Care
News
At-Home Intracranial Recordings Reveal Circadian Rhythms in Patients with PD
08/27/2024
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi)...
08/27/2024
Annals of Long-Term Care
News
PD-Related Genes Contribute to Disease in 15% of Patients
08/05/2024
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
MRI-Guided Focused Ultrasound Subthalamotomy for Treating Parkinson Disease
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use